Publication: Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand
Issued Date
2005-11-01
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-33645220783
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.88, No.11 (2005), 1624-1629
Suggested Citation
Peera Buranakitjaroen, Chaicharn Deerochanawong, Pongamorn Bunnag Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand. Journal of the Medical Association of Thailand. Vol.88, No.11 (2005), 1624-1629. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/16764
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand
Other Contributor(s)
Abstract
Background: Microalbuminuria represents the earliest clinical evidence of diabetic nephropathy, and is a marker of increased cardiovascular (CV) morbidity and mortality. Objectives: This analysis of Thai data from the Microalbuminuria Prevalence Study (MAPS) assessed the prevalence of macroalbuminuria and microalbuminuria in hypertensive patients with type 2 diabetes. Design: Cross-sectional clinic-based epidemiological study. Material and Method: A total of 100 patients were enrolled, of which 97 patients constituted the per-protocol population (patients with bacteriuria and haematuria were excluded). Patients attended one study visit with no follow-up. Results: Overall, the prevalence of diabetic kidney disease was high, with macroalbuminuria contributing 13.4% [9.9-16.9; 95% confidence interval (CI)] and microalbuminuria contributing 43.3% [38.3-48.3; 95%CI]. Conclusion: Annual screening for microalbuminuria is recommended for all patients with type 2 diabetes, as early treatment is critical for reducing CV risks. Clinical studies have shown that renin-angiotensin system inhibitors can slow the progression of diabetic nephropathy.